SCHEMBL4247895

SCHEMBL4247895

CC(C)(C)OC(=O)N1Cc2ccc(NC3CCNCC3)cc2C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.52
ALDH1A1 P00352 2/20 0.51
HDAC1 Q13547 1/20 0.51
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
MAPK1 P28482 2/20 0.50
DDB1 Q16531 2/20 0.50
CRBN Q96SW2 2/20 0.50
MAPT P10636 1/20 0.50
HTT P42858 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
NAMPT P43490 3/20 0.46
ESR2 Q92731 1/20 0.46
NR1H2 P55055 1/20 0.45
PIK3CA P42336 1/20 0.44
MTOR P42345 1/20 0.44
ROCK2 O75116 1/20 0.43
PTPN1 P18031 2/20 0.42
PTPN2 P17706 1/20 0.42
PTPN6 P29350 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22632810 0.87 ALDH1A1 (0.58) ALDH1A1HDAC1NPC1RAB9AMAPK1
SCHEMBL19954031 0.85 ALDH1A1 (0.61) ALDH1A1HDAC1NPC1RAB9AMAPK1
SCHEMBL12853755 0.82 ALDH1A1 (0.63) ALDH1A1NPC1RAB9AMAPK1DDB1
SCHEMBL31335838 0.80 NR1H2 (0.63) ALDH1A1NPC1RAB9AMAPK1DDB1
SCHEMBL10269535 0.80 ALDH1A1 (0.63) ALDH1A1NPC1RAB9AMAPK1DDB1
SCHEMBL4240787 0.79 ALDH1A1 (0.46) PDK2ALDH1A1NPC1RAB9AMAPK1
SCHEMBL12177841 0.79 HDAC1 (0.57) ALDH1A1HDAC1NPC1RAB9AMAPK1
SCHEMBL4239069 0.78 ALDH1A1 (0.53) ALDH1A1NPC1RAB9AMAPK1MAPT
SCHEMBL24124818 0.78 DDB1 (0.67) NPC1RAB9ADDB1CRBN
SCHEMBL30313369 0.78 DDB1 (0.67) NPC1RAB9ADDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7491735-B2 Chemokine receptor binding compounds GENZYME CORPORATION (US) 2009-02-17 US disclosed
EP-1708703-A4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC (CA) 2008-04-09 EP disclosed
EP-1708703-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2006-10-11 EP disclosed
US-20050277670-A1 Chemokine receptor binding compounds ANORMED INC. 2005-12-15 US disclosed
WO-2005059107-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277670-A1 Chemokine receptor binding compounds CCR5, CXCR3, CCL5 PDK2 2250/4885ALDH1A1 3358/4885HDAC1 1392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.